|
⚲
|
| Keyboard |
| GOEL David E
✚
|
|
|---|---|
| CIK # | 0001548144 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001548144] | |
| 4 | [0001548144] | |
| 5 | [0001548144] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock, par value $0.001 per share
|
2025-12-15 | Sell | 7,500,000 | $1.33 | 9,975,000 |
|
Alumis Inc ALMS
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2025-05-21 | Grant | 4,493,741 | ||
|
Acelyrin Inc SLRN
"Common Stock, par value $0.00001 per share (""Common Stock"")"
|
2025-05-21 | Disposed to issuer | 9,334,735 | $0.00 | |
|
Alumis Inc NASDAQ
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-07-01 | Conversion | 20,000,000 | $0.00 | |
|
Alumis Inc NASDAQ
"Common Stock, par value $0.0001 per share (""Common Stock"")"
|
2024-07-01 | Conversion | 8,145,966 | ||
|
Alumis Inc NASDAQ
Series C Redeemable Convertible Preferred Stock · derivative
|
2024-07-01 | Conversion | 12,745,916 | $0.00 | |
|
Alumis Inc NASDAQ
Common Stock
|
2024-07-01 | Grant | 2,500,000 | $16.00 | 40,000,000 |
|
Alumis Inc NASDAQ
Series B-2 Redeemable Convertible Preferred Stock · derivative
|
2024-07-01 | Conversion | 5,336,489 | $0.00 | |
|
Aura Biosciences Inc AURA
Common Stock, par value $0.00001 per share (Common Stock)
|
2023-11-09 | Buy | 1,560,000 | $9.00 | 14,040,000 |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock, par value $0.001 per share
|
2023-06-20 | Buy | 4,760,000 | $22.66 | 107,861,600 |
|
Acelyrin Inc SLRN
Series C Redeemable Convertible Preferred Stock · derivative
|
2023-05-09 | Conversion | 3,709,429 | $0.00 | |
|
Acelyrin Inc SLRN
"Common Stock, par value $0.00001 per share (""Common Stock"")"
|
2023-05-09 | Conversion | 9,334,735 | ||
|
Acelyrin Inc SLRN
Series B Redeemable Convertible Preferred Stock · derivative
|
2023-05-09 | Conversion | 5,625,306 | $0.00 | |
|
Aura Biosciences Inc AURA
"Common Stock, par value $0.00001 per share (""Common Stock"")"
|
2022-12-05 | Buy | 1,250,000 | $12.00 | 15,000,000 |
|
Aura Biosciences Inc AURA
"Common Stock, par value $0.00001 per share (""Common Stock"")"
|
2021-11-02 | Conversion | 2,327,870 | ||
|
Aura Biosciences Inc AURA
Common Stock
|
2021-11-02 | Buy | 1,785,000 | $14.00 | 24,990,000 |
|
Aura Biosciences Inc AURA
Series E Convertible Preferred Stock · derivative
|
2021-11-02 | Conversion | 2,327,870 | $0.00 | |
|
Adaptive Biotechnologies Corp ADPT
Common Stock
|
2021-03-10 | Sell | 25,732 | $41.47 | 1,067,106 |
|
Adaptive Biotechnologies Corp ADPT
Common Stock
|
2021-03-10 | Sell | 30,268 | $42.38 | 1,282,758 |
|
Adaptive Biotechnologies Corp ADPT
Common Stock
|
2021-03-09 | Sell | 34,302 | $41.16 | 1,411,870 |
| showing 20 of 58 most recent transactions | |||||